FOXP3 and pancreatic neoplasm: The most prevalent type of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC), and an increase in Foxp3 in the tumor microenvironment of pancreatic cancer affects immune cells (DCs), which are antigen-presenting cells, impairing the body’s ability to mount an immune defense (63).